Hepatocyte Nuclear Factor 4 alpha (HNF4α) is critical for hepatic differentiation. Recent studies have highlighted its role in inhibition of hepatocyte proliferation and tumor suppression.
Introduction
HNF4α is known as the master regulator of hepatocyte differentiation due its role in establishing hepatocyte-specific gene expression during embryonic development (1, 2) , stabilizing the hepatic transcription factor network (3) and maintaining hepatocyte function (4) . HNF4α regulates genes involved in xenobiotic metabolism, carbohydrate metabolism, fatty acid metabolism, bile acid synthesis, blood coagulation, and ureagenesis (5) . Expression of HNF4α induces hepatocyte-like characteristics in induced pluripotent stem cells (6) and forced expression of HNF4α can be used to differentiate and decrease cancer progression in hepatocellular carcinomas (HCC) and hepatoma cell lines (7, 8) . Furthermore, decreased HNF4α expression leads to loss of hepatic function and causes decompensation in cirrhotic rats (9) .
Recent studies from our laboratory and others have revealed anti-proliferative properties of HNF4α (10, 11) . HNF4α is anti-proliferative in kidney cells (12) and pancreatic β-cells (13) .
Furthermore, hepatocyte-specific deletion of HNF4α (HNF4α-KO) in mice results in spontaneous hepatocyte proliferation (10, 11) and promotes formation of diethylnitrosamineinduced HCCs (14) .
During liver regeneration after 2/3 partial hepatectomy (PH), the most widely used model to study liver regeneration, multiple redundant mechanisms regulate initiation and termination of hepatocyte regeneration (15) . Understanding the mechanisms that govern adult hepatocytes to navigate between quiescent and proliferative states could result in therapeutic targets for inducing hepatocyte proliferation during impaired regeneration or inhibiting excess proliferation during carcinogenesis. Despite its role in maintaining hepatocyte differentiation and quiescence, little is known about the role of HNF4α in hepatocyte regeneration or how decreased HNF4α, a condition commonly found in diseased human livers (9, (16) (17) (18) , would impact regeneration. In this study, we investigated the role of HNF4α in regulation of liver regeneration after PH using wildtype (WT) and HNF4α-KO mice. Our studies revealed that HNF4α is indispensible for survival after PH and a critical component of termination of liver regeneration.
Materials and Methods
Animal Care and Surgeries.
Animals were housed in facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care at the University of Kansas Medical Center under a standard 14-hr dark/10-hr light cycle with access to chow and water ad libitum. All studies were approved by the Institutional Animal Care and Use Committee at the University of Kansas Medical Center. PH surgeries were performed and tissue samples obtained as previously described (19) . Surgeries were performed between 9:00 am and 11:00 am. For liver regeneration in normal conditions, two-month-old male C57BL6/J mice were euthanized at 0, 1, 3, 6, 12, 24 and 48 hr, and 3, 5, 7, and 14 days after PH with 3 mice per time point. To study the effects of HNF4α deletion on liver regeneration, seven days before surgery HNF4α-floxed mice were injected intraperitoneally with AAV8-TBG-eGFP or AAV8-TBG-CRE resulting in WT and hepatocyte-specific HNF4α-KO animals, respectively. These vectors were purchased from Penn Vector Core (Philadelphia, PA) and injected as previously described (20) . WT and HNF4α-KO mice were euthanized at 0, 1, 2, 5, 7 and 14 days after PH with 3-5 mice per group. Only two HNF4α-KO mice survived to be included at the 7 day time point. HNF4α reexpression was accomplished by tail vein injection of 2 x 10 11 viral genomes/mouse of AAV8-CMV-HNF4α generated in the laboratory of Dr. Holger Willenbring. Male HNF4α-floxed mice were injected with AAV8-TBG-CRE to induce HNF4α deletion and 7 days later were injected with AAV8-CMV-HNF4α to restore HNF4α expression. Liver and serum samples were collected seven days after AAV8-CMV-HNF4α injection. Next, this system was used to test if HNF4α reexpression could rescue HNF4α-KO mice after partial hepatectomy. WT and HNF4α-KO mice underwent PH 7 days after injection with AAV8-TBG-eGFP or AAV8-TBG-CRE with four mice per treatment. Tail vein injection with reexpression vector or control saline occurred 2 days after surgery to allow for initiation of regeneration. Overexpression of HNF4α was accomplished using Tet-On-HNF4α transgenic mouse line developed at the KUMC Transgenic and Gene Targeting Institutional Facility. These mice contained a reverse tetracycline-controlled transcriptional activator which was constitutively expressed with a C/EBPβ promoter. In the presence of the tetracycline-derivative Doxycycline (Dox), this transcription factor binds a tetracycline response element (TRE) upstream of an shRNA-resistant HNF4α gene (kind gift from Dr. Stephen A. Duncan, Medical University of South Carolina). Tet-On-HNF4α were heterozygous for both transgenes. Doxycycline was administered for two weeks prior to surgery by replacing drinking water with a 1 mg/mL Dox in 5% Sucrose solution. Untreated mice were given 5% sucrose solution only. Two mice were used for the untreated 6 hour time point and three to five mice used for all other treatments and time points.
Protein Isolation and Western blotting.
Nuclear and cytoplasmic lysates and RIPA extracts were prepared and used for Western blot analysis as reported (21) . Primary antibodies are provided in Supplemental Table 1 .
Densitometric analysis was performed using Image Studio Lite (LI-COR Biosciences).
Real Time PCR.
RNA isolation, conversion to cDNA and Real time PCR analysis was performed as previously described (22) . RNA sequencing and bioinformatics analysis were performed as previously described (14) . Genes of interest were identified based on RNA-Seq analysis comparing gene expression in livers from WT and hepatocyte-specific HNF4α-KO mice (14) . Primer sequences are provided in Supplemental Table 2 .
Staining Procedures.
Paraffin-embedded liver sections (4-μm thick) were used for immunohistochemical staining of proliferating cell nuclear antigen (PCNA) as previously described (19) . PCNA positive hepatocyte nuclei were quantified by counting three 40x fields per slide for each liver sample.
Serum Bilirubin
Total serum bilirubin was determined using the Total Bilirubin kit from Pointe Scientific (Cat #B7576) according to manufacturer's protocol.
Statistical Analysis
Results are expressed as mean ± standard error. One Way ANOVA and Student's t test was applied to all analyses with p < 0.05 being considered significant.
Results

Decreased HNF4α Protein Expression and Transcriptional Activity During Initiation of
Regeneration After Partial Hepatectomy.
First, we investigated the expression and activity of HNF4α in liver regeneration after PH in C57BL/6J mice. We measured protein expression of HNF4α adult isoforms using Western blotting in freshly prepared nuclear ( Fig. 1A, 1C ) and cytoplasmic ( Fig. 1B ) protein extracts.
Nuclear HNF4α levels started declining at 1 (hour) hr post-PH reaching the lowest level at 6 hr post-PH. Nuclear HNF4a protein expression started rising at 12 hr, increased higher than the 0 hr levels peaking at 3 days post PH and then declined again to reach the 0 hr levels by 7 days post-PH ( Fig. 1A, 1C ). Cytoplasmic HNF4α expression continually declined below 0 hr levels until 12h post-PH, then started to rise but did not return to 0 hr pre-PH levels till 14 days after PH.
The expression of adult isoform of HNF4α mRNA did not change over the entire regeneration time course ( Fig. 1D ).
We assessed HNF4α transcriptional activity by qPCR analysis of its target genes at the 0, 6 and 12 hr time points when nuclear HNF4α protein levels were at their lowest levels. We observed decreased expression of positive target genes (14) (Apoa2, ApoB, Ces3, Cldn1, Cyp2c37, Dio1, F12, Ugt2b1) at the 6 and 12-hr time points compared to 0 hr expression levels ( Fig. 1E ). We have previously identified novel negative targets of HNF4α, which are suppressed by HNF4α in the normal liver (14) . qPCR analysis showed induction of HNF4α negative target genes (Akr1b7, Ccnd1, Ect2, Myc) at the 6 and 12 hr time points ( Fig. 1F ). Together, these data indicate a decrease in HNF4α activity at the onset of regeneration which is consistent with the changes we observed in HNF4α protein expression ( Fig. 1A-C ).
HNF4α Overexpression Delays But Does Not Prevent Hepatocyte Proliferation During Liver Regeneration
We used a Tet-On-HNF4α transgenic mouse system (23) to overexpress HNF4α in hepatocytes to test if the anti-proliferative effects of HNF4α would prevent hepatocyte proliferation during the initiation of liver regeneration (Supp. Fig. 1 ). Western blot analysis confirmed increased HNF4α in nuclear lysates from livers of doxycycline (Dox)-treated Tet-On-HNF4α mice at 6 hours post-PH (Supp. Fig. 2A ). This resulted in fewer PCNA-positive nuclei in Dox-treated mice 6 hours post-PH. However, no difference in PCNA staining was observed between untreated and Dox treated mice 48 hours post-PH (Supp. Fig. 2B ). Interestingly, Dox treatment inhibited the occurrence of transient steatosis 48 hours post-PH (Supp. Fig 2C) .
Hepatocyte-Specific HNF4α-KO Mice Do Not Survive After PH.
Next, we investigated the effect of hepatocyte-specific HNF4α deletion on liver regeneration after PH. WT and HNF4α-KO mice underwent PH and were euthanized at 1, 2, 5, 7 and 14 days after surgery. HNF4α protein remained undetectable in HNF4α-KO mice throughout the time course after PH (Fig 2A) . We observed 100% mortality in the HNF4α-KO group by day 11 post-PH ( Fig. 2B) . Interestingly, the recovery of liver weight was similar between WT and HNF4α-KO groups until 5 days post PH (Fig. 2C ). Serum bilirubin was significantly elevated in HNF4α-KO mice at days 1, 2 and 5 post-PH ( Fig. 2D ). While serum bilirubin in HNF4α-KO animals did decrease over time, this assay was only performed on surviving mice and most animals in this group had died at later time points. We investigated changes in HNF4α target gene expression in WT and HNF4α-KO mice at 7 days after PH, which revealed a significant decrease in expression of positive target genes including Alas2, Apoa2, Apob, Cldn1, Cyp2c37, Dio1, F12 and Ugt2b1 ( Fig 3A) . Similarly, the expression of the negative targets Akr1b7, CcnD1, Cdkn3, Defb1, Ect2, Egr1, Myc and Slc34a2 was increased at 7 days post-PH ( Fig. 3B ).
Increased Hepatocyte Proliferation in HNF4α-KO Livers Throughout Regeneration.
Western blot analysis indicated that protein expression of cyclin D1, the cyclin involved in driving G0 to G1 and G1 to S cell cycle transition, was significantly increased in HNF4α-KO livers at all time points. The expression of CDK4, the cyclin dependent kinase interacting with cyclin D1 was lower in HNF4α-KO liver at days 1 and 2 post PH but increased to levels 
Altered Proliferative Signaling in HNF4α-KO Mice During Regeneration
We investigated the mechanism of sustained hepatocyte proliferation throughout regeneration in HNF4α-KO mice by Western blot analysis of pathways commonly involved in hepatocyte proliferation. We focused on pathways downstream of primary hepatocyte mitogen signaling as well as those known to activate hepatocyte proliferation in the absence of HNF4α (14, 24) . Most interestingly, we observed complete loss of total EGFR and total c-MET protein expression in HNF4α-KO animals at all time points throughout regeneration ( Fig. 5A ). Next, we examined Wnt/β-catenin pathway members ( Fig. 5B ). Total β-catenin levels were similar in WT and HNF4α-KO mice before PH and did not change throughout the time course. However, inactive (Thr41/Ser45-phosphorylated) β-catenin was elevated in the WT animals at days 1 and 2 post-PH. Phosphorylated β-catenin was greater in HNF4α-KO compared to WT mice 5 days post-PH.
Densitometric analysis of inactive to total β-catenin ratio suggested activation of β-catenin was higher in HNF4α-KO mice at 1 and 2 days post-PH. Total GSK-3β levels did not change for both groups throughout the time course. Inactive (ser9-phospho) GSK-3β was higher in both groups at days 1 and 5 post-PH, but no difference was observed between groups. Next, we investigated activation of several MAPK members including AKT, p38 and ERK1/2 ( Fig. 5C ).
No difference in total AKT and total p38 protein levels was observed between groups throughout regeneration. Phosphorylation of AKT was inhibited in the HNF4α-KO mice as compared to WT at days 0, 1 and 5 post-PH but was similar to WT at day 2 after PH. Phosphorylation 
RNAseq revealed sustained increase in pro-proliferative and anti-differentiation signaling in
HNF4α-KO Mice Post-PH
To gain insights in the comprehensive signaling changes in HNF4α-KO livers after PH, we performed RNA-Seq analysis at days 2 and 5 post-PH. These time points were selected to match the peak hepatocyte proliferation (day 2 post PH) and early termination phase of regeneration (day 5 post PH) in the liver regeneration process. Overall, a similar number of genes (~1,000) increased and decreased at day 2 and day 5 after PH in HNF4α-KO mice as compared to WT mice (Supp. Table 3 ). Ingenuity Pathway Analysis (IPA) predicted activation and inhibition of transcription factors based on gene expression changes between genotypes. At 2 days post-PH (Table 1) , IPA predicted activation of effectors of proinflammatory signaling (EGR1, IRF3, IRF6, IRF7) and proproliferative transcription factors (JUN, RB1, P300, TCF3) in HNF4α-KO liver. Interestingly, HNF4α-KO also showed activation of TGF-β signaling as indicated by activation of SMAD2 and SMAD4 as well as inhibition of SMAD7 (25) . The transcription factors predicted to be inhibited 2 days post-PH included HNF4α and its coactivators HNF1A and PPARGC1A (PGC1A). Furthermore, Estrogen Receptor α (Esrra), which is known to regulate gene expression in coordination with HNF4α and PGC1A (26) , was also predicted to be inhibited. TAF4, a known HNF4α cofactor which is required for HNF4α transcriptional activity (27) , was also inhibited. MED1, which is essential for PPARα activity and required for survival after PH (28) , was inhibited in HNF4α-KO 2 days post-PH. ZBTB20, a known suppressor of hepatocyte proliferation and repressor of alpha-fetoprotein (29, 30) , was predicted to be inhibited.
At day 5 post-PH (Table 2) , the analysis predicted activation of transcription factor proinflammatory damage associated molecular pattern (DAMP) protein HMGB1 in HNF4α-KO mice indicating sustained inflammatory signaling in HNF4α-KO mice throughout regeneration.
The TGFβ effector SMAD2 was also activated at day 5 post-PH. Proliferative marker EP300 was activated at day 5 post-PH. The HNF4α negative target gene and proliferative marker CCND1 was activated in the HNF4α-KO group at day 5 post-PH indicated sustained proliferative signaling compared to WT mice. Activation of SNAI2 was predicted in the HNF4α-KO group at 5 days post-PH. SNAI2 is repressed by HNF4α and is known to promote EMT (31) .
PLAG1 is a fetal gene overexpressed in hepatoblastomas (32) and was predicted to be activated in the HNF4α-KO group at day 5. Activation of TRIM24, a transcription factor with oncogenic activity (33) , was predicted at day 5 post PH in the HNF4α-KO mice. Transcription factors including HNF4A, HNF1A, PPARGC1A, and Esrra were inhibited at day 2 post-PH and continued to be inhibited at day 5 post-PH. Inhibition of SIRT2 was observed at 5 days post-PH in HNF4α-KO mice consistent with its known role in sharing many of the same target genes as HNF4α (34) . PPARGC1B is a known coactivator of PPARGC1A and was inhibited. NCOA2 and EBF1, known tumor suppressors (35, 36) , were inhibited in HNF4α-KO mice day 5 post-PH.
NFIX, a transcription factor known to inhibit development of HCC(37), was inhibited. Finally, the master regulators of sterol and lipid metabolism, SREBF1 and SREBF2, were inhibited 5 days post-PH.
IPA analysis also predicted activity of diseases and organ function based on gene expression
differences between WT and HNF4α-KO mice at 2 and 5 days post-PH. The comparison at day 2 post-PH (Supp. Table 4 ) predicted HNF4α-KO mice would exhibit activation of pathways involving inflammation, tumorigenesis and wound healing. Inhibited functions included numerous basic liver processes such as transport, metabolism and synthesis of cholesterol, lipids, bile acids and xenobiotics. This pattern continued at day 5 post-PH (Supp. Table 5 ). Activated functions continued to be related to cell proliferation, tumorigenesis and inflammation.
Additionally, functions related to embryonic organ tissue development were activated in the HNF4α-KO group. Functions related to transport and metabolism of lipids, cholesterol and vitamins remained inhibited in HNF4α-KO mice 5 days post-PH.
Reexpression of HNF4α Restores Hepatocyte Quiescence and Gene Expression and Extends
Survival of HNF4α-KO Animals Post-PH
Next we tested if reexpression of HNF4α in hepatocytes by intravenous injection of AAV8-CMV-HNF4α could rescue HNF4α-KO mice after PH by restoring HNF4α transcriptional activity after cell division. First we reexpressed HNF4α in HNF4α-KO mice and measured HNF4α target gene expression. HNF4α reexpression increased total c-MET and total EGFR protein expression to WT levels and reduced cyclin D1 expression to WT levels (Fig. 6A ).
Hepatocyte proliferation was assessed by immunohistochemical analysis of PCNA positive nuclei. High levels of hepatocyte proliferation were observed in the HNF4α-KO group. HNF4α reexpression resulted in decreased hepatocyte proliferation compared to HNF4α-KO mice (Fig.   6B,C) . Finally, we reexpressed HNF4α in HNF4α-KO mice 2 days post-PH. This treatment improved survival compared to HNF4α-KO mice (Fig. 6D ).
Discussion
HNF4α is the master regulator of hepatocyte differentiation because it is required for hepatocyte differentiation during embryonic liver development and it maintains hepatocyte specific gene expression in adult hepatocytes (3) (4) (5) . HNF4α also exerts strong anti-proliferative effects on hepatocytes and decreased HNF4α expression and activity results in loss of quiescence, which can lead to HCC (14, 17, 18) . Despite being recognized as one of the strongest anti-proliferative proteins in the liver, the role of HNF4α during liver regeneration is not known. We investigated the role of HNF4α in liver regeneration after PH, where adult hepatocytes exit the physiological quiescent state and enter the cell cycle before returning to the quiescent state once liver regeneration has been completed. We hypothesized that decreased HNF4α expression and function would occur during the initiation of regeneration to alleviate the antiproliferative effects of HNF4α as quiescent hepatocytes enter the cell cycle during the initiation of liver regeneration.
Indeed, we observed decreased nuclear and cytoplasmic levels of HNF4α occurring within hours after surgery. This decreased protein expression was not due to changes in transcription of the HNF4α gene because there were no changes in HNF4α mRNA post-PH. Decreased periportal HNF4α staining after PH has been previously reported (38) . However, HNF4α expression during liver regeneration has never been studied in a time course at this level of resolution until now. Posttranslational modifications (PTMs) of HNF4α which result in decreased nuclear localization are known (39, 40) , and some PTMs can lead to proteosomal degradation of HNF4α (41) . Future studies are needed to investigate whether these posttranslational modifications, especially phosphorylation of HNF4α, is the mechanism behind the decrease in HNF4α protein levels during the initiation of liver regeneration. Decrease in expression of HNF4α protein after PH resulted in decrease in its transcriptional activity as measured by its target genes, which play a critical role in liver physiology (14) . Our observations independently reproduce a microarray study describing decreased HNF4α target gene expression 4 hours post-PH (42) . This highlights functional differences between quiescent and proliferating hepatocytes and suggests restoring HNF4α in hepatocytes responding to chronic injury could successfully restore hepatic function (9, 43) .
Next, we hypothesized that overexpressing HNF4α in hepatocytes at time points after PH when HNF4α levels were decreased would prevent hepatocytes from proliferating and halt or delay initiation of liver regeneration. Interestingly, our experiments with Tet-On driven HNF4α expression revealed no significant effect on overall hepatocyte proliferation after PH. These data suggest that rapid down regulation of HNF4α after PH may accelerate hepatocyte cell cycle entry, but is not absolutely necessary for initiation of cell cycle progression after PH. It is also possible that HNF4α overexpression resulted in delayed initiation because the mechanism responsible for HNF4α degradation was still active and more time was needed to degrade the overexpressed protein. Inhibiting the mechanism responsible for HNF4α degradation could be a better strategy to study the effects of increased HNF4α expression during initiation of liver regeneration once those mechanisms are established. One interesting observation from the HNF4α overexpression study was the lack of steatosis in HNF4α overexpressing mice, which is known to occur after PH (44) . These data indicate that the initial loss of HNF4α could be mechanistically involved in the transient steatosis observed following PH and those mechanisms may be independent of initiation of cell proliferation.
The most striking observation from our studies is 100% mortality in HNF4α-KO mice following PH within 11 days secondary to loss of hepatic function. Several HNF4α-KO mice exhibited signs of hepatic encephalopathy such as lack of righting reflex prior to death (data not shown).
Decreased hepatic function further manifested as elevated bilirubin levels in HNF4α-KO mice after PH. The fact that HNF4α-KO hepatocytes were not able to compensate for loss of HNF4α function (as measured by target gene expression) further support the role of HNF4α as a master regulator of hepatic differentiation. Consistent with our previous findings that HNF4α is antiproliferative in hepatocytes, the HNF4α-KO mice showed a consistently higher cell proliferation, which never declined after PH. But the lack of HNF4α resulted in failure to redifferentiate the newly divided cells resulting in significant decline in hepatic function leading to death. This was evident by the complete lack of hepatocyte differentiation genes at 7 days post PH in HNF4α-KO mice as compared to the WT mice. This was consistent with the significant increase in nuclear HNF4α expression observed in the control mice ( Fig. 1) at days 3 and 5 after PH, the time points when the cell proliferation decreases and redifferentiation starts. Taken together, these data clearly demonstrate that HNF4α-mediated differentiation of the newly divided hepatocytes is an essential part of the termination of regeneration and failure to redifferentiate can lead to cell and animal mortality.
Another important observation in our studies was the complete lack of MET and EGFR expression in HNF4α-KO mice. It is known that signaling induced by primary hepatic mitogens HGF and EGF family members (EGF, TGFα etc.) via their cognate receptors c-MET and EGFR is essential for liver regeneration after PH (24) . However, HNF4α-KO mice seem to be an exception to this rule. We observed complete loss of c-MET and EGFR expression in HNF4α-KO mice, yet hepatocyte proliferation occurred in these mice at high levels before and throughout liver regeneration. To address the alternate mechanisms at play, we investigated several known pathways including Wnt/β-catenin pathway and MAPK signaling. Whereas, significantly higher β-catenin signaling was observed in HNF4α-KO mice as evident by decrease in phosphorylated (inactive) β-catenin, this was observed only during the early time points. Similarly, the AKT, p38 and ERK-1/2 pathways also revealed only moderate differences between WT and HNF4α-KO mice after PH, which can not explain the sustained proliferation of hepatocytes in HNF4α-KO mice. However, we observed a significant activation of c-myc in HNF4α-KO mice consistent with the previous studies (14) . Also, the role of myc in liver regeneration and cancer is well documented. Our studies show that HNF4α deleted hepatocytes lose two of the primary mitogenic pathways, namely MET and EGFR, but proliferation continues mainly via myc overexpression.
The RNAseq analysis further revealed mechanisms that drive continued proliferation and also the mechanisms that lead to liver failure and death of the HNF4α-KO mice after PH. We investigated days 2 post-PH, the time points with peak proliferation, and 5 days post-PH the time point when termination of regeneration begins. At both time points, the HNF4α-KO livers exhibited a proinflammatory and profibrotic transcriptional profile. Elevated inflammation in HNF4α-KO mice was not caused by hepatocellular injury, as there was no difference in ALT levels or histopathological changes between groups (data not shown). However, previous studies have reported elevated bile acid levels in HNF4α-KO livers, which could cause increased inflammatory signaling (45) . Furthermore, many HNF4α negative target genes such as EGR1 are pro-inflammatory. IPA analysis also supported our findings of dedifferentiation and loss of hepatocyte function in HNF4α-KO mice. IPA predicted consistent inhibition of several prominent hepatocyte functions in HNF4α-KO at day 2 and day 5 post-PH. However, we observed a shift in the characteristics of activated functions between the two time points. Most of the activated functions in HNF4α-KO mice at day 2 included those involved in inflammation.
However, the activated functions in HNF4α-KO mice at day 5 included many more functions involved in proliferation, tumorigenesis and a developmentally immature phenotype in addition to inflammation. Furthermore, HNF4α-KO mice at day 5 were predicted to express higher levels of known oncogenes (TRIM24, SNAI2, PLAG1) which were not activated at day 2. This transformation from an abnormal regenerative response to the beginnings of a pathological condition raise the question of how hepatocytes with poor expression of HNF4α may respond to chronic or intermittent low level liver injury. The decreased expression of HNF4α expressed in many liver diseases and HCC may be an example of the innate regenerative capability of the liver contributing to the progression of liver disease.
We observed that reexpression of HNF4α in HNF4α-KO mice using the AAV8 resulted in restoration of majority of the WT gene expression pattern. However, when HNF4α construct was introduced after PH, we did not observe complete prevention of death. This may be due to several reasons including the timing of HNF4α reexpression (two days after PH may be too early), the possibility that dividing cells may have decreased sensitivity to AAV8 and that the dividing cells may reject AAV8-mediated introduction of exogenous material. Nevertheless, we did observe a significant increase in survival following HNF4α reintroduction in HNF4α-KO mice.
In summary, our studies are the first to examine and manipulate HNF4α expression over multiple time points throughout the initiation, progression and termination of liver regeneration after partial hepatectomy. Our findings suggest downregulation of HNF4α may contribute to 
